ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01646008
Recruitment Status : Completed
First Posted : July 20, 2012
Last Update Posted : December 3, 2015
Sponsor:
Information provided by (Responsible Party):
Susana Arias Rivera, Hospital Universitario Getafe

Brief Summary:
The purpose of this study is to study the correlation between carbon dioxide measured by capnography at the enf of exhalation and arterial blood in COPD patients with nasal cannula in critical care unit.

Condition or disease Intervention/treatment
Correlation Between Exhaled Carbon Dioxide and in Arterial Blood Other: To measure carbon dioxide by capnography and arterial blood Other: to measure carbon dioxide by capnography and arterial blood

Study Type : Observational
Actual Enrollment : 32 participants
Time Perspective: Prospective
Official Title: Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood in Chronic Obstructive Pulmonary Disease (COPD) in Intensive Care Unit With Nasal Cannula
Study Start Date : April 2012
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
respiratory Other: To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
Other: to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adult COPD patients admitted to the ICU who consent
Criteria

Inclusion Criteria:

  • Adults
  • COPD patients

Exclusion Criteria:

  • Under-aged
  • Pregnant
  • Major burns

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01646008


Locations
Spain
Hospital Universitario de Getafe
Getafe, Madrid, Spain, 28905
Sponsors and Collaborators
Hospital Universitario Getafe
Investigators
Principal Investigator: Susana Arias-Rivera, Graduate Hospital Universitario de Getafe, Spain

Responsible Party: Susana Arias Rivera, Registered Nurse, Hospital Universitario Getafe
ClinicalTrials.gov Identifier: NCT01646008     History of Changes
Other Study ID Numbers: Carbon dioxide Getafe
First Posted: July 20, 2012    Key Record Dates
Last Update Posted: December 3, 2015
Last Verified: December 2015

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases